ArticleCell communication and signaling : CCS2026
Usnic acid inhibits colorectal cancer liver metastasis by targeting CRYAB phosphorylation and inducing ferroptosis.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundColorectal cancer liver metastasis (CCLM) presents a significant challenge in oncology, characterized by aggressive progression and poor prognosis. Usnic acid (UA), a secondary metabolite derived from the lichen Usnea, has shown extensive bioactivity, particularly notable anticancer effects. Despite the well-established pro-apoptotic role of UA through reactive oxygen species (ROS) generation, its influence within the hypoxic tumor microenvironment, particularly in CCLM, remains inadequately elucidated.
methodsIn this study, we employed an integrative approach utilizing multi-omics analyses and molecular dynamics simulations to identify CRYAB (αB-crystallin) as a UA target in CCLM. We assessed the impact of UA on the phosphorylation status of serine 59 (S59) in CRYAB using cellular thermal shift assays. By developing organoid models from both CCLM and primary colorectal cancer tissues, we examined tumor characteristics, pathway enrichment, and the effects of hypoxic conditions on CRYAB dynamics. We utilized mutation analysis to explore the functional implications of S59 phosphorylation.
resultsOur findings reveal that CRYAB is upregulated in CCLM tissues with increased S59 phosphorylation. UA binds with high affinity to CRYAB, significantly decreasing S59 phosphorylation in a dose-dependent manner. CCLM organoids exhibited elevated CRYAB and FGFR1 expression, along with activation of pathways involved in epithelial-mesenchymal transition (EMT), hypoxia, and proliferation. Hypoxia further promoted CRYAB phosphorylation and organoid growth; however, UA treatment mitigated these effects, leading to apoptosis and reduced cell migration. Notably, mutations at S59 altered CRYAB localization and modified downstream signaling, highlighting its role in tumor metastasis.
conclusionsThis study reveals that CRYAB phosphorylation is a key driver of liver metastasis progression in colorectal cancer and confirms that usnic acid exerts its anti-metastatic effects by targeting this post-translational modification. Mechanistically, beyond its known pro-apoptotic activity, usnic acid induces ferroptosis by inhibiting CRYAB phosphorylation at site S59. These findings establish a mechanistic framework for usnic acid as a potential therapeutic agent against metastatic colorectal cancer, highlighting the therapeutic potential of targeting CRYAB phosphorylation and ferroptosis in managing colorectal cancer liver metastases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.